Browsing Tag
Receptor
68 posts
Study links acid-reducing drugs to increased risk of migraine
People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people…
April 25, 2024
HEROS 2.0 trial results published
Researchers at Texas Children’s Cancer Center and the Center for Cell and Gene Therapy at Baylor College of…
April 24, 2024
Animal study suggests early Western diet exposure linked to lasting memory issues
In a recent study published in the journal Brain, Behavior, and Immunity, researchers developed an initial-life Western diet…
April 19, 2024
Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients
A recent study published in the New England Journal of Medicine conducted a trial of lixisenatide to assess…
April 18, 2024
New research pinpoints key pathways in prostate cancer’s vulnerability to ferroptosis
In a recent review published in the journal Nature Reviews Urology, researchers examined the molecular mechanisms and metabolic…
April 18, 2024
Exploring the versatile roles of tissue macrophages beyond immune defense
A recent study published in Science Immunology summarized the role of resident tissue macrophages (RTMs) in homeostasis and…
April 17, 2024
Research unveils bispecific antibodies for B-cell lymphoma treatment
A new research paper was published in Oncotarget’s Volume 15 on April 12, 2024, entitled, “Novel therapeutic bispecific…
April 16, 2024
Study reveals novel approach to promote efficient uptake of ASOs into cancer cells
Antisense oligonucleotides (ASOs) are next-generation drugs that can treat disease by blocking the transfer of harmful messages from…
April 16, 2024
Ketamine’s rapid impact on depression linked to immune system pathways
In a recent study published in Molecular Psychiatry, researchers review the anti-inflammatory effects of ketamine in the peripheral and…
April 16, 2024
Insilico Medicine’s AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy
In recent years, cancer immunotherapy, exemplified by PD-1 and its ligand PD-L1 blockade, has made remarkable advances. But…
April 13, 2024